|
| |
| | | 68008 | | 04.11.2021 | | Biogen Switzerland AG | | | | | | | 03.11.2026 | | | | | | 01.99. | | | | 01.99. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Tysabri 150 mg/ml | Injektionslösung in einer Fertigspritze | Injection solution in prefilled syringe (Natalizumab 150 mg/ml) | L04AG03 | |
|
|
|
